46% power in study planning? [Study As­sess­ment]

posted by sam – India, 2013-08-01 15:40 (4301 d 19:15 ago) – Posting: # 11149
Views: 25,734

Hi Helmut,

❝ Can you please be more specific. What do you mean by “not in concurrence to the other subjects data”?


Means the T/R ratio of these subjects are in between 23-35%. But other subjects have a ratio from 60-100%

❝ You can exclude this subjects only in an additional evaluation and present it as a sensitivity analysis.


Please suggest some test which we can apply for the exclusion of AUCt parameter for only two subjects.

❝ I would try that (i.e., AUCt is not a reliable/relevant metric of absorption for ER formulations). Back it up with a comparison of half lives.


ok

❝ Can you elaborate? With T/R of 84% and a CV of 26% you would have needed 342 (!) subjects to obtain 80% power (and still 260 for 70% power – which is the lowest any serious IEC should accept, IMHO). Was your target power only 46% – running another “casino-type” study? Bad.


I Really apologize for the mistake, the ratio is 84.71 and CV for the pilot study is 19.11.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
134 visitors (0 registered, 134 guests [including 8 identified bots]).
Forum time: 10:56 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5